Active ingredients: phenytoin
The Therapeutic Goods Administration (TGA) has a recall notice on this product.
Dilantin (phenytoin sodium) 30 & 100 mg capsule bottles and Dilantin (phenytoin) Infatabs 50 mg tablet bottle
Recall Action Commencement Date: 2/12/2016
Multiple lots affected
TGA Recall Reference: RC-2016-RN-01523-1
Dilantin (phenytoin sodium) 30 mg capsule bottle
AUST R Number: 14306
Dilantin (phenytoin sodium) 100 mg capsule bottle
AUST R Number: 14305
Dilantin (phenytoin) Infatabs 50 mg tablet bottle
AUST R Number: 14308
Further information on this recall can be found at http://apps.tga.gov.au/PROD/SARA/arn-detail.aspx?k=RC-2016-RN-01523-1
What it is used for
DILANTIN is indicated for the control of grand mal and psychomotor seizures. DILANTIN will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. Besides its effectiveness in controlling seizures, DILANTIN frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that DILANTIN is valuable in the prevention of seizures occurring during or after neurosurgery. Phenytoin serum level determinations may be necessary for optimal dosage adjustments (see Dosage and Administration).
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
a yellow triangular tablet with flat sides bevelled edges, break line on one side and 'P-D 007' on the other
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on July 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine contains the active ingredients:
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Pregnant or planning a pregnancy?
For the active ingredient phenytoin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems